Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harte-Hanks

4.55
+0.03000.66%
Post-market: 4.550.00000.00%16:05 EDT
Volume:12.37K
Turnover:55.75K
Market Cap:33.48M
PE:-1.11
High:4.69
Open:4.40
Low:4.27
Close:4.52
Loading ...

Conviction stock-picking drives biotech success: a biotech market review of 2024

LiveWire
·
17 Jan

BRIEF-HHS To Provide $211 Million To Rapid Response Partnership Vehicle Consortium To Enhance mRNA Platform Capabilities

Reuters
·
17 Jan

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

GlobeNewswire
·
14 Jan

UPDATE 1-US agency declares California wildfires a public health emergency

Reuters
·
11 Jan

BRIEF-HHS Secretary Xavier Becerra Declares Public Health Emergency For California To Aid Health Care Response To Wildfires

Reuters
·
11 Jan

TOMI Environmental Solutions Positioned to Address Growing Global Disease Threats with SteraMist Technology

GlobeNewswire
·
10 Jan

Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

Dow Jones
·
08 Jan

Press Release: Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Dow Jones
·
08 Jan

Basilea provides portfolio update and outlook

GlobeNewswire
·
08 Jan

ASX December health sector winners… and a 91pc drop for a trial-flopped stock

Stockheads
·
08 Jan

Surgeon General Wants Alcohol Warning Labels to Note Cancer Risk

Investopedia
·
04 Jan

ASX healthcare 2024 winners and losers, plus what’s next for 2025

Stockheads
·
31 Dec 2024

The US proposes rules to make healthcare data more secure

The Verge
·
28 Dec 2024

Eli Lilly, Amgen Sue HHS for Unlawful Certifications of Drug Discount Program Recipients

MT Newswires Live
·
24 Dec 2024

Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients

MT Newswires Live
·
24 Dec 2024

Press Release: Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera(R) (ceftobiprole) in the United States

Dow Jones
·
16 Dec 2024